Januvia Patent expiry is February 2, 2019

Discussion in 'Merck' started by anonymous, Nov 5, 2018 at 10:11 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Why are we being lied to that the patent doesn’t run out until 2022? The patent for IMPROVEMENT OF GLYCEMIC CONTROL IN ADULTS WITH TYPE 2 DIABETES MELLITUS IN COMBINATION WITH METFORMIN AND/OR A PPAR-GAMMA AGONIST AND/OR SULFONYLUREA AND/OR INSULIN. Soon after that will be generics. Definitely going to start looking. Not going to let this place blindside me.
     

  2. anonymous

    anonymous Guest

    After Januvia goes off patent all that is really left is Keytruda. When that goes off patent the Merck will be forced to shut its doors. This company has a garbage track record of bringing great products to market since Januvia. KEYTRUDA was absolute luck. That product was on a shelf, forgotten about. Then the genius scientists at Merck saw that BMS was having success with their PD1. Time to dust off the product discovered by Organon, and further developed by Schering. But Merck takes all the bows with how great their R&D is. Terrible joke!!
     
  3. anonymous

    anonymous Guest

    100% accurate! But MRL still thinks they are top performers.
     
  4. anonymous

    anonymous Guest

    I thought you were full of shit but I found out you are spot on. They almost left the last Hope for growth in our company on a shelf. The R&D here is third rate at best
     
  5. anonymous

    anonymous Guest

    "Merck will be forced to shut its doors." LOL!! Merck has more money that God and will never be forced to end...As long as their are poison potions to concoct, willing guinea pigs to ingest them and get jabbed, and payors to fleece, Merck will thrive until the end of time...
     
  6. anonymous

    anonymous Guest

    Keytruda is paying the bills.
     
  7. anonymous

    anonymous Guest

    GM said the same thing in the 80s.
     
  8. anonymous

    anonymous Guest

    This company makes money in spite of itself!
     
  9. anonymous

    anonymous Guest

    Its a litigious issue with Januvia having to do with the salts patented with Januvia. From a legal perspective a generic could be launched in 2019. It would not be identical due to the fillers but Sun Pharma (India) has every intention of launching this in 2019. MC will substitute the generic version.
     
  10. anonymous

    anonymous Guest

    When sales start declining because of patent expiries and better competition, the stock will plummet. We are overvalued right now. Ken looks like a hero right now but it is a facade. Keytruda is not enough to keep investors happy when the revenue from all of the other products slows considerably. Januvia sales are very important, and we aren’t meeting expectations with it. The new Steglashit is garbage. Our sleep agent was asleep at launch, and continues to be unimpressive. Vaccines sales are not sustainable long term. Zostavax crashed and burned with the launch of Shingrix. Pneumovax is losing a lot of business to Prevnar for 19-64 year olds. There are always shortages with Hep B and several other vaccines. Gardasil is doing well, but is not enough.

    Ken will be leaving soon with a lot of money and a big smile. Merck does have a lot of money but will not be able to sustain this structure long term. We will have to get much leaner and make strategic acquisitions in oncology.
     
  11. anonymous

    anonymous Guest

    Excellent and factual assessment...you sound like you actually know what you are talking about and are really smart...

    You know people that are smart and tell it like it is have no business at Merck right?

    Mediocrity is the name of the game here...
     
  12. anonymous

    anonymous Guest

    i can't believe this shit co is still around. What is the sales force now? 200 reps. All shit drugs.
     
  13. anonymous

    anonymous Guest

    My husband is on Januvia, and because its cost is now $460 every 30 days (Silverscript), I've been researching internationally. Canada sells it for $159/30. But India has it for $59/42. Maybe they already have it available.
     
  14. anonymous

    anonymous Guest

    The glory days are just about over
     
  15. anonymous

    anonymous Guest

    Nothing is free bitch get off your
    Cheap ass I won't buy it for you probably if he lost 150 pounds he would be fine. I can just imagine the breadth of you ass!
     
  16. anonymous

    anonymous Guest

    That person was only stating facts.
    You have no business spewing your toxic hate on this site

     
  17. anonymous

    anonymous Guest

    It is my business when Freeloaders are constantly robbing from neighbors who work and support themselves. The I Am Entitled Mob needs squashed.
     
  18. anonymous

    anonymous Guest

    Sorry asswipe, my husband's family has a history of diabetes...and he is in pretty good shape, 6', 190 lbs. Have you ever heard of adult onset Type 2 Diabetes? Uh huh, I thought not. You just sit at your POA's grinding away thinking you're gonna tap whatever is available. What a joke.

    I bet your Mother is very proud of you.

    Most folks on Medicare/Social Security cannot afford Januvia.
     
  19. anonymous

    anonymous Guest

    Get a job and leave the workers out of your whining. If you can't buy our product get another compound there are many out there!
     
  20. anonymous

    anonymous Guest

    Wow, I bet you are in the unemployment line before the end of March. I'd hate to be your DM.